High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance

A. Broyl, R. Kuiper, M. van Duin, B. van der Holt, L. el Jarari, U. Bertsch, S. Zweegman, A. Buijs, D. Hose, H.M. Lokhorst, H. Goldschmidt, P. Sonneveld

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)624-627
JournalBlood
Volume121
Issue number4
DOIs
Publication statusPublished - 2013

Cite this

Broyl, A., Kuiper, R., van Duin, M., van der Holt, B., el Jarari, L., Bertsch, U., ... Sonneveld, P. (2013). High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance. Blood, 121(4), 624-627. https://doi.org/10.1182/blood-2012-06-438101